Market

Corcept Therapeutics CEO Joseph Belanoff sells $178,097 in stock

Corcept Therapeutics CEO Joseph Belanoff sells $178,097 in stock
Read More

Related Posts

Home-builder ETFs down in 2025 after brutal February as these worries weigh

Home-builder ETFs down in 2025 after brutal February as...

HP Inc. was proactive about the impact of tariffs, and it may be paying off

HP Inc. was proactive about the impact of tariffs, and ...

Nvidia’s stock is in a funk. Earnings didn’t help, but here’s what could.

Nvidia’s stock is in a funk. Earnings didn’t help, but ...

Oil heads for first monthly drop since November as economic uncertainty weighs

Oil heads for first monthly drop since November as econ...

Virgin Galactic’s new spacecraft looms large as company eyes future profitability

Virgin Galactic’s new spacecraft looms large as company...

South Korea's pension fund logs record 15% investment return in 2024

South Korea's pension fund logs record 15% investment r...